277 related articles for article (PubMed ID: 15734932)
1. Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats.
Thoeny HC; De Keyzer F; Chen F; Ni Y; Landuyt W; Verbeken EK; Bosmans H; Marchal G; Hermans R
Radiology; 2005 Mar; 234(3):756-64. PubMed ID: 15734932
[TBL] [Abstract][Full Text] [Related]
2. Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging.
Thoeny HC; De Keyzer F; Vandecaveye V; Chen F; Sun X; Bosmans H; Hermans R; Verbeken EK; Boesch C; Marchal G; Landuyt W; Ni Y
Radiology; 2005 Nov; 237(2):492-9. PubMed ID: 16192323
[TBL] [Abstract][Full Text] [Related]
3. Treatment of rodent liver tumor with combretastatin a4 phosphate: noninvasive therapeutic evaluation using multiparametric magnetic resonance imaging in correlation with microangiography and histology.
Wang H; Sun X; Chen F; De Keyzer F; Yu J; Landuyt W; Vandecaveye V; Peeters R; Bosmans H; Hermans R; Marchal G; Ni Y
Invest Radiol; 2009 Jan; 44(1):44-53. PubMed ID: 19034028
[TBL] [Abstract][Full Text] [Related]
4. Retrospective power analysis: when?
Erturk SM
Radiology; 2005 Nov; 237(2):743; author reply 743; discussion 743-4. PubMed ID: 16244281
[No Abstract] [Full Text] [Related]
5. Diffusion-weighted MRI of hepatic tumor in rats: comparison between in vivo and postmortem imaging acquisitions.
Sun X; Wang H; Chen F; De Keyzer F; Yu J; Jiang Y; Feng Y; Li J; Marchal G; Ni Y
J Magn Reson Imaging; 2009 Mar; 29(3):621-8. PubMed ID: 19243058
[TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted magnetic resonance imaging allows noninvasive in vivo monitoring of the effects of combretastatin a-4 phosphate after repeated administration.
Thoeny HC; De Keyzer F; Chen F; Vandecaveye V; Verbeken EK; Ahmed B; Sun X; Ni Y; Bosmans H; Hermans R; van Oosterom A; Marchal G; Landuyt W
Neoplasia; 2005 Aug; 7(8):779-87. PubMed ID: 16207480
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two vascular-disrupting agents at a clinically relevant dose in rodent liver tumors with multiparametric magnetic resonance imaging biomarkers.
Wang H; Cona MM; Chen F; Yu J; Feng Y; Li J; Keyzer FD; Marchal G; Ni Y
Anticancer Drugs; 2012 Jan; 23(1):12-21. PubMed ID: 21857503
[TBL] [Abstract][Full Text] [Related]
8. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
[TBL] [Abstract][Full Text] [Related]
9. Renal masses: characterization with diffusion-weighted MR imaging--a preliminary experience.
Zhang J; Tehrani YM; Wang L; Ishill NM; Schwartz LH; Hricak H
Radiology; 2008 May; 247(2):458-64. PubMed ID: 18430878
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted imaging as predictor of therapy response in an animal model of Ewing sarcoma.
Reichardt W; Juettner E; Uhl M; Elverfeldt DV; Kontny U
Invest Radiol; 2009 May; 44(5):298-303. PubMed ID: 19346963
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted MR imaging allows monitoring the effect of combretastatin A4 phosphate on rabbit implanted VX2 tumor model: 12-day dynamic results.
Shao H; Ni Y; Dai X; Zhang J; Chen F; Fan G; Sun Z; Li Y; Zhou H; Xu K
Eur J Radiol; 2012 Mar; 81(3):578-83. PubMed ID: 21454029
[TBL] [Abstract][Full Text] [Related]
12. Intra-individual comparison of therapeutic responses to vascular disrupting agent CA4P between rodent primary and secondary liver cancers.
Liu YW; De Keyzer F; Feng YB; Chen F; Song SL; Swinnen J; Bormans G; Oyen R; Huang G; Ni YC
World J Gastroenterol; 2018 Jul; 24(25):2710-2721. PubMed ID: 29991876
[TBL] [Abstract][Full Text] [Related]
13. Colon tumor growth and antivascular treatment in mice: complementary assessment with MR elastography and diffusion-weighted MR imaging.
Jugé L; Doan BT; Seguin J; Albuquerque M; Larrat B; Mignet N; Chabot GG; Scherman D; Paradis V; Vilgrain V; Van Beers BE; Sinkus R
Radiology; 2012 Aug; 264(2):436-44. PubMed ID: 22692038
[TBL] [Abstract][Full Text] [Related]
14. Bilateral diffusion-weighted MR imaging of breast tumors with submillimeter resolution using readout-segmented echo-planar imaging at 7 T.
Bogner W; Pinker K; Zaric O; Baltzer P; Minarikova L; Porter D; Bago-Horvath Z; Dubsky P; Helbich TH; Trattnig S; Gruber S
Radiology; 2015 Jan; 274(1):74-84. PubMed ID: 25341078
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas.
Uhl M; Saueressig U; Koehler G; Kontny U; Niemeyer C; Reichardt W; Ilyasof K; Bley T; Langer M
Pediatr Radiol; 2006 Dec; 36(12):1306-11. PubMed ID: 17031633
[TBL] [Abstract][Full Text] [Related]
16. Normal and transplanted rat kidneys: diffusion MR imaging at 7 T.
Yang D; Ye Q; Williams DS; Hitchens TK; Ho C
Radiology; 2004 Jun; 231(3):702-9. PubMed ID: 15163810
[TBL] [Abstract][Full Text] [Related]
17. Osteogenic sarcoma: noninvasive in vivo assessment of tumor necrosis with diffusion-weighted MR imaging.
Lang P; Wendland MF; Saeed M; Gindele A; Rosenau W; Mathur A; Gooding CA; Genant HK
Radiology; 1998 Jan; 206(1):227-35. PubMed ID: 9423677
[TBL] [Abstract][Full Text] [Related]
18. Pituitary macroadenomas: preoperative evaluation of consistency with diffusion-weighted MR imaging--initial experience.
Pierallini A; Caramia F; Falcone C; Tinelli E; Paonessa A; Ciddio AB; Fiorelli M; Bianco F; Natalizi S; Ferrante L; Bozzao L
Radiology; 2006 Apr; 239(1):223-31. PubMed ID: 16452397
[TBL] [Abstract][Full Text] [Related]
19. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.
Kamel IR; Bluemke DA; Eng J; Liapi E; Messersmith W; Reyes DK; Geschwind JF
J Vasc Interv Radiol; 2006 Mar; 17(3):505-12. PubMed ID: 16567675
[TBL] [Abstract][Full Text] [Related]
20. Role of diffusion-weighted magnetic resonance imaging in differentiation between the viable and necrotic parts of head and neck tumors.
Razek AA; Megahed AS; Denewer A; Motamed A; Tawfik A; Nada N
Acta Radiol; 2008 Apr; 49(3):364-70. PubMed ID: 18365828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
